A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT06847334 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06847334
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-27
- Primary completion
- 2027-04-09
- Enrollment
- 772
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.